65 results
8-K
EX-99.1
DVAX
Dynavax Technologies Corporation
6 Aug 24
Dynavax Reports Second Quarter 2024 Financial Results and Provides Business Updates
4:05pm
of previous process improvements.
Research and Development Expenses (R&D). R&D expenses for the second quarter of 2024 increased to $15.0 million, compared
8-K
EX-99.1
DVAX
Dynavax Technologies Corporation
8 May 24
Dynavax Reports First Quarter 2024 Financial Results
4:05pm
.
Research and Development Expenses (R&D). R&D expenses for the first quarter of 2024 decreased to $13.5 million, compared to $13.6 million for the first
8-K
EX-99.1
DVAX
Dynavax Technologies Corporation
22 Feb 24
Dynavax Reports Fourth Quarter and Full Year 2023 Financial Results
4:05pm
value across our business, including through investing to drive the HEPLISAV-B market opportunity, advancing and expanding our R&D efforts, and pursuing … , and $50.2 million for the full year 2023, compared to $40.1 million for the full year 2022.
Research and Development Expenses (R&D). R&D expenses
8-K
EX-99.1
DVAX
Dynavax Technologies Corporation
2 Nov 23
Dynavax Reports Third Quarter 2023 Financial Results and Raises Full Year Revenue Guidance
4:10pm
obligations and product delivery under the prior CpG 1018 adjuvant collaboration agreements as of December 31, 2022.
Research and Development Expenses (R&D). R … &D expenses for the third quarter of 2023 increased to $14.1 million, compared to $13.0 million for the third quarter of 2022. The increase
8-K
EX-99.1
az8d5
3 Aug 23
Dynavax Reports Second Quarter 2023 Financial Results and Raises Full Year Revenue Guidance
4:11pm
8-K
EX-99.1
9acy8p
2 May 23
Dynavax Reports First Quarter 2023 Financial Results
4:11pm
8-K
EX-99.1
hp1t9tr7yco1dbcq1
3 Nov 22
Dynavax Reports Third Quarter 2022 Financial Results
4:10pm
8-K
EX-99.1
a7ion17ce8dmk4
4 Aug 22
Dynavax Reports Second Quarter 2022 Financial Results
4:09pm
8-K
EX-99.1
mb6bg
5 May 22
Dynavax Reports First Quarter 2022 Financial Results
4:04pm
8-K
EX-99.1
goivezzv
4 Nov 21
Dynavax Reports Third Quarter 2021 Financial Results
4:50pm
8-K
EX-99.1
8wgf9z7a29q6t
4 Aug 21
Dynavax Announces Second Quarter 2021 Financial Results
4:06pm
8-K
EX-99.1
dg3lf0z5 cum9zi5xdg
6 May 21
Dynavax Announces First Quarter 2021 Financial Results
4:08pm
8-K
EX-99.1
le19ori5n361nngtk9
25 Feb 21
Dynavax Announces Fourth Quarter and Full Year 2020 Financial Results
4:07pm
8-K
86p m00vizk0v
21 Jan 21
Departure of Directors or Certain Officers
9:01am
8-K
EX-99.1
tjd2idsr9h8zbt3xl
5 Nov 20
Dynavax Announces Third Quarter 2020 Financial Results
4:08pm
8-K
EX-99.1
r9i1jngqg 33
6 Aug 20
Dynavax Announces Second Quarter 2020 Financial Results
4:06pm